Globally, approximately 300,000 people die of oral cancer annually.
Existing optical oral cancer screening technologies, cost thousands of dollars and lack specificity.
The majority of oral cancers are detected in Stages 3 and 4, when mortality is >70%.
However, mortality in Stages 1 and 2 is only 20%
High accuracy: ± Predictive values greater than 0.95
Low cost: Less than $1,000
User-friendly: Efficient control panel
Multi function: Oral/Cancer Screening switch
Paired Phone Application
Risk prediction algorithm
Information integrated into one Android application
Leading to a stratification of the patient into high, medium, and low risk for oral cancer
Give the patient suggestions regarding to the result.
An exfoliative cytology brush
A glass slide
shipping materials to a partnered pathology laboratory
Results are uploaded to the Android app
Creates a recurring revenue for the clinician